Knowledge Hub

Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)

Press Release   •   Nov 09, 2016 07:15 EST

MarketResearchReports.biz has recently announced the addition of a market study “ Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020) ”, is a comparative analysis of the global market.

Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle and brain’s response to neuronal injury. People suffering from End Stage Renal Disease (ESRD), HIV or undergoing chemotherapy are not able to produce enough EPO on their own and thus, are administered with synthetic or recombinant erythropoietin which has the similar sequence of amino acids. Recombinant erythropoietin is a kind of therapeutic agent devised using DNA technology.

On the bases of their molecular structure, EPO drugs can be divided into five categories: epoetin-alfa, epoetin-beta, epoetin-omega, epoetin-delta and darbepoetin-alfa. Among these epoetin-alfa and darbepoetin-alfa are most commonly prescribed EPO drugs.

The global EPO drugs market is expected to experience negative growth rate, primarily due to expiry of patents of two most common EPO drugs, epoetin-alfa and darbepoetin-alfa, allowing the entry of biosimilars; posing a serious threat to EPO drugs market. However, the Asia-Pacific region is expected to experience boom period majorly due to improving disposable income and better government medical reimbursement policies.

The report “Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlook (2016-2020)” analyzes the development of this market, with focus on the US and Asia-Pacific markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players: Johnson & Johnson, Amgen, Roche and Teva Pharmaceutical Industries Limited are being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global EPO market along with the study of the regional markets.

Download The sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/862810

Table Of Content

1. Overview

1.1 Erythropoietin

1.2 Recombinant Human Erythropoietin (rHuEPO)

1.3 Applications of EPO and Adverse Effects

2. Global EPO Market

2.1 Global EPO Drug Market by Value

2.2 Global EPO Drug Market Forecast by Value

2.3 Global EPO Biosimilar Market by Value

2.4 Global EPO Biosimilar Market Forecast by Value

2.5 Global EPO Market by Drug Type

2.6 Global EPO Drug Market Forecast by Application

2.7 Global EPO Drug Market by Region

3. Regional Markets

3.1 The US

3.1.1 The US EPO Drug Market Forecast by Value

3.1.2 The US EPO Drugs Market by Applications

3.2 Asia-Pacific

3.2.1 China EPO Drug Market by Value

3.2.2 China EPO Drug Market Forecast by Value

3.2.3 China EPO Drug Market by Application

3.2.4 Malaysia EPO Drug Market Forecast by Value

3.2.5 Korea EPO Drug Market Forecast by Value

3.2.6 Thailand EPO Drug Market Forecast by Value

3.2.7 Philippines EPO Drug Market Forecast by Value

3.2.8 Vietnam EPO Drug Market Forecast by Value

4. Market Dynamics

4.1 Growth Drivers

4.1.1 Rising Number of Patients Suffering from ESRD

4.1.2 Increasing Global Healthcare Expenditure Per Capita

4.1.3 Rising Global GDP Per Capita

4.1.4 Escalating Aged Population

4.1.5 Rising Cases of HIV and Cancer Induced Anemia

4.1.6 Increasing Sales of Prescription Drugs

4.2 Trends

4.2.1 Entry of Biosimilar

4.2.2 Shift from Short-Acting to Long-Acting EPO Drugs

4.2.3 Underpenetrated Dialysis and Oncology Market in Asia

4.3 Challenges

4.3.1 Biosimilar Hampering the EPO Drug Market Growth

4.3.2 Declining Price of EPO drugs

4.3.3 High R&D Cost

5. Competitive Landscape

5.1 Global EPO Drug Market

5.1.1 Global EPO Drugs Market Share by Company

5.1.2 Global EPO Drugs Market by Products

5.2 The US EPO Drug Market

5.2.1 The US EPO Drugs Market Share by Company

5.3 Asia-Pacific EPO Drug Market

5.3.1 China EPO Market Share by Company

5.3.2 Japan EPO Market Share by Company